|
Shukra Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
1396.40 Cr.
|
P/BV
|
16.21
|
Book Value (Rs.)
|
1.97
|
|
52 Week High/Low (Rs.)
|
65/12
|
FV/ML
|
1/1
|
P/E(X)
|
145.88
|
|
Bookclosure
|
18/09/2025
|
EPS (Rs.)
|
0.22
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 50.40 | 19.32 |
| Total Income From Operations | 50.40 | 19.32 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 12.76 | 6.15 |
| Purchase of Traded Goods | 0.00 | 0.86 |
| Increase/Decrease in Stocks | -2.85 | -0.67 |
| Employees Cost | 6.67 | 4.36 |
| Depreciation | 2.44 | 2.06 |
| Other Expenses | 5.79 | 3.20 |
| Total Expenses | 24.80 | 15.97 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 25.60 | 3.35 |
| Other Income | 3.64 | 2.74 |
| P/L Before Interest, Excpt. Items & Tax | 29.24 | 6.09 |
| Interest | 0.83 | 0.32 |
| P/L Before Exceptional Items & Tax | 28.41 | 5.77 |
| P/L Before Tax | 28.41 | 5.77 |
| Tax | 4.63 | 1.58 |
| P/L After Tax from Ordinary Activities | 23.77 | 4.19 |
| Net Profit/Loss For the Period | 23.77 | 4.19 |
| Net P/L After Minority Interest & Share Of Associates | 23.77 | 4.19 |
| | | |
| Equity Share Capital | 43.79 | 43.79 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.54 | 0.96 |
| Diluted EPS (Rs.) | 0.54 | 0.96 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.54 | 0.96 |
| Diluted EPS (Rs.) | 0.54 | 0.96 |
| | | |
| PBITOE Margin (%) | 50.79 | 17.33 |
| PBTE Margin (%) | 56.35 | 29.85 |
| PBT Margin (%) | 56.35 | 29.85 |
| PAT Margin (%) | 47.16 | 21.68 |
| PAT After MI And SOA Margin (%) | 47.16 | 21.68 |
